Covid-19: France launches into vaccine production
The anti-Covid-19 vaccine developed by the American Moderna will be produced in France from March 2021 by the Recipharm laboratory, in Monts, in Indre-et-Loire.
AP - John Locher
Text by: RFI Follow
3 min
From the end of February-beginning of March, four pharmaceutical sites will start producing these vaccines, announced President Emmanuel Macron after a meeting with major French and European laboratories.
The government's goal is to offer a vaccine to all French adults who want it by the end of the summer.
Publicity
Read more
Four pharmaceutical sites in France will start producing anti-Covid vaccines, developed by other laboratories.
Delpharm will produce the Pfizer / BioNTech vaccine in its Normandy plant.
The Recipharm Laboratory for the Moderna vaccine in Monts, in Indre-et-Loire.
And Fareva the CureVac vaccine at its sites in Pau and Val-de-Reuil, in the South-West region.
The first two vaccines have already been approved in the European Union, so their production will start quickly.
But the CureVac vaccine is still pending.
France is awaiting marketing authorization.
Its production should not start until May.
►
To read also: Macron ensures that all French people who wish will be vaccinated by the end of the summer
Sanofi will start production around July
As for the last pharmaceutical site, it belongs to the French laboratory Sanofi, which is developing its own vaccine.
But this was several months late.
Its production should start around July, according to the Minister for Industry.
Ultimately, the government's goal is to produce more doses quickly, and to anticipate, by producing vaccines adapted to the variants, by the fall.
►
Also read: Headlines: other people's vaccines
Start of the week,
LR president of the Pays de la Loire region, Christelle Morancais, has stepped up to the plate to denounce what she considers a failure of France and Europe regarding the vaccine produced by the Franco-Austrian biotech Valneva, including the head office is located in Saint-Herblain, near Nantes.
An anti-Covid vaccine that will ultimately first be intended for the British because London was the first to invest in its production.
“
Initially, we contacted a number of governments for help.
The United Kingdom responded first, in large part no doubt because we were already there, and also because they immediately believed in our inactivated vaccine, they were the first to react,
”explained Franck Grimaud, the director. general, in an interview with AFP, February 1.
Newsletter
Receive all the international news directly in your mailbox
I subscribe
Follow all the international news by downloading the RFI application
google-play-badge_FR
France
Vaccines
Coronavirus
Emmanuel Macron
On the same subject
Macron ensures that all French people who wish will be vaccinated by the end of the summer
French press review
In the spotlight: other people's vaccines
In the race for the anti-Covid vaccine, French research is trampling